$6.13 Billion is the total value of TPG GP A, LLC's 39 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LFST | LifeStance Health Group Inc | $1,302,364,838 | +50.4% | 175,284,635 | 0.0% | 21.23% | +24.9% | |
| Life Time Group Holdings Inc | $687,392,891 | +33.4% | 43,069,730 | 0.0% | 11.20% | +10.8% | ||
| CWK | Cushman & Wakefield PLC | $367,139,346 | -15.4% | 34,832,955 | 0.0% | 5.98% | -29.7% | |
| PGNY | Progyny Inc | $297,110,000 | +3.1% | 9,250,000 | 0.0% | 4.84% | -14.4% | |
| PropertyGuru Group Ltc | $242,488,640 | +16.0% | 48,497,728 | 0.0% | 3.95% | -3.6% | ||
| ALLO | Allogene Therapeutics Inc | $92,458,552 | -21.5% | 18,716,306 | 0.0% | 1.51% | -34.8% | |
| TRTX | TPG RE Fin Tr Inc | $51,450,016 | +6.9% | 7,086,779 | 0.0% | 0.84% | -11.1% | |
| Nerdy Inc | $49,003,185 | +85.8% | 11,723,250 | 0.0% | 0.80% | +54.2% | ||
| PCVX | Vaxcyte Inc | $44,613,793 | -21.8% | 1,190,336 | 0.0% | 0.73% | -35.1% | |
| ATUS | Altice USA Inccl a | $28,325,733 | -25.7% | 8,282,378 | 0.0% | 0.46% | -38.2% | |
| Rallybio Corp | $17,292,244 | -13.1% | 3,028,414 | 0.0% | 0.28% | -27.7% | ||
| AMRX | Amneal Pharmaceuticals Inc | $17,136,986 | -30.2% | 12,328,767 | 0.0% | 0.28% | -42.1% | |
| FUSN | Fusion Pharmaceuticals Inc | $9,620,263 | +19.7% | 2,551,794 | 0.0% | 0.16% | -0.6% | |
| Vacasa Inc | $4,114,218 | -23.6% | 4,275,845 | 0.0% | 0.07% | -36.8% | ||
| UXIN | Uxin Ltdads | $2,149,179 | -22.2% | 959,455 | 0.0% | 0.04% | -35.2% | |
| Nerdy Inc*w exp 08/16/202 | $130,000 | +182.6% | 200,000 | 0.0% | 0.00% | +100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| LIFESTANCE HEALTH GROUP INC | 8 | Q3 2023 | 23.5% |
| LIFE TIME GROUP HOLDINGS INC | 8 | Q3 2023 | 12.4% |
| CUSHMAN WAKEFIELD PLC | 8 | Q3 2023 | 9.6% |
| Progyny Inc | 8 | Q3 2023 | 6.4% |
| ELEVANCE HEALTH INC | 8 | Q3 2023 | 5.2% |
| MICROSOFT CORP | 8 | Q3 2023 | 3.7% |
| ALLOGENE THERAPEUTICS INC | 8 | Q3 2023 | 3.3% |
| COMCAST CORP NEW | 8 | Q3 2023 | 2.7% |
| PEGASYSTEMS INC | 8 | Q3 2023 | 2.6% |
| JOHNSON CTLS INTL PLC | 8 | Q3 2023 | 2.5% |
View TPG GP A, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-04 |
| SC 13D/A | 2024-03-04 |
| SC 13D/A | 2024-02-28 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-02-13 |
| SC 13D/A | 2024-02-12 |
View TPG GP A, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.